Forte Biosciences, Inc. (FBRX) Retained Earnings (2016 - 2020)
Forte Biosciences (FBRX) has disclosed Retained Earnings for 5 consecutive years, with -$46.9 million as the latest value for Q3 2020.
- On a quarterly basis, Retained Earnings rose 82.55% to -$46.9 million in Q3 2020 year-over-year; TTM through Sep 2020 was -$46.9 million, a 82.55% increase, with the full-year FY2019 number at -$5.0 million, up 97.7% from a year prior.
- Retained Earnings was -$46.9 million for Q3 2020 at Forte Biosciences, down from -$41.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $18000.0 in Q1 2019 to a low of -$289.7 million in Q1 2020.
- A 5-year average of -$127.0 million and a median of -$141.6 million in 2017 define the central range for Retained Earnings.
- Peak YoY movement for Retained Earnings: soared 100.01% in 2019, then plummeted 1609433.33% in 2020.
- Forte Biosciences' Retained Earnings stood at -$128.0 million in 2016, then tumbled by 30.41% to -$166.9 million in 2017, then fell by 29.33% to -$215.9 million in 2018, then soared by 97.7% to -$5.0 million in 2019, then tumbled by 843.66% to -$46.9 million in 2020.
- Per Business Quant, the three most recent readings for FBRX's Retained Earnings are -$46.9 million (Q3 2020), -$41.8 million (Q2 2020), and -$289.7 million (Q1 2020).